TY - JOUR
T1 - The genotype-based morphology of aldosterone-producing adrenocortical disorders and their association with aging
AU - Gao, Xin
AU - Yamazaki, Yuto
AU - Tezuka, Yuta
AU - Omata, Kei
AU - Ono, Yoshikiyo
AU - Morimoto, Ryo
AU - Nakamura, Yasuhiro
AU - Satoh, Fumitoshi
AU - Sasano, Hironobu
N1 - Funding Information:
Fumitoshi Satoh and Hironobu Sasano were supported by grants from Ministry of Health, Labour and Welfare in Japan (H 29 Nanji-Japan 046).
Publisher Copyright:
Copyright © 2021 Korean Endocrine Society
PY - 2021/2
Y1 - 2021/2
N2 - Primary aldosteronism (PA) is the most common cause of secondary hypertension, and is associated with an increased incidence of cardiovascular events. PA itself is clinically classified into the following two types: unilateral PA, mostly composed of aldosterone-producing adenoma (APA); and bilateral hyperaldosteronism, consisting of multiple aldosterone-producing micronodules (APMs) and aldosterone-producing diffuse hyperplasia. Histopathologically, those disorders above are all composed of compact and clear cells. The cellular morphology in the above-mentioned aldosterone-producing disorders has been recently reported to be closely correlated with patterns of somatic mutations of ion channels including KCNJ5, CACNA1D, ATP1A1, ATP2B3, and others. In addition, in non-pathological adrenal glands, APMs are frequently detected regardless of the status of the renin-angiotensin-aldosterone system (RAAS). Aldosterone-producing nodules have been also proposed as non-neoplastic nodules that can be identified by hematoxylin and eosin staining. These non-neoplastic CYP11B2-positive nodules could represent possible precursors of APAs possibly due to the presence of somatic mutations. On the other hand, aging itself also plays a pivotal role in the development of aldosterone-producing lesions. For instance, the number of APMs was also reported to increase with aging. Therefore, recent studies indicated the novel classification of PA into normotensive PA (RAAS-independent APM) and clinically overt PA.
AB - Primary aldosteronism (PA) is the most common cause of secondary hypertension, and is associated with an increased incidence of cardiovascular events. PA itself is clinically classified into the following two types: unilateral PA, mostly composed of aldosterone-producing adenoma (APA); and bilateral hyperaldosteronism, consisting of multiple aldosterone-producing micronodules (APMs) and aldosterone-producing diffuse hyperplasia. Histopathologically, those disorders above are all composed of compact and clear cells. The cellular morphology in the above-mentioned aldosterone-producing disorders has been recently reported to be closely correlated with patterns of somatic mutations of ion channels including KCNJ5, CACNA1D, ATP1A1, ATP2B3, and others. In addition, in non-pathological adrenal glands, APMs are frequently detected regardless of the status of the renin-angiotensin-aldosterone system (RAAS). Aldosterone-producing nodules have been also proposed as non-neoplastic nodules that can be identified by hematoxylin and eosin staining. These non-neoplastic CYP11B2-positive nodules could represent possible precursors of APAs possibly due to the presence of somatic mutations. On the other hand, aging itself also plays a pivotal role in the development of aldosterone-producing lesions. For instance, the number of APMs was also reported to increase with aging. Therefore, recent studies indicated the novel classification of PA into normotensive PA (RAAS-independent APM) and clinically overt PA.
KW - Adenoma
KW - Adrenal glands
KW - Aldosterone
KW - Pathology
UR - http://www.scopus.com/inward/record.url?scp=85102992824&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102992824&partnerID=8YFLogxK
U2 - 10.3803/ENM.2021.101
DO - 10.3803/ENM.2021.101
M3 - Article
C2 - 33677921
AN - SCOPUS:85102992824
SN - 2093-596X
VL - 36
SP - 12
EP - 21
JO - Endocrinology and Metabolism
JF - Endocrinology and Metabolism
IS - 1
ER -